Families often describe it the same way on the first call: “It’s only tramadol. The doctor prescribed it.” That framing is understandable, and it is also where admissions mistakes start. Tramadol is an opioid with a second, non-opioid mechanism layered on top, and both matter when someone stops taking it. This guide walks through what tramadol dependence looks like in residential treatment, why withdrawal needs medical supervision, and the specific details to have ready before you call admissions.

Tramadol at a glance: the numbers that shape an admission

Tramadol has been a federally controlled Schedule IV substance since August 18, 2014, and its prescribing label caps immediate-release tablets at 400 mg per day. For a person entering residential treatment, the dose actually taken in the last 30 days, counted in milligrams rather than pills, is the single most useful fact the admissions team can receive, because both seizure risk and withdrawal planning scale with it. Tramadol also comes in extended-release forms and in a combination tablet with acetaminophen, and each version changes the medical picture differently.

Many people who become dependent on tramadol did not set out to misuse anything. They started with a legitimate prescription for back pain, a dental procedure or arthritis, and the dose crept up over months. The National Institute on Drug Abuse (NIDA) describes how tolerance and physical dependence can develop with prescription opioids taken as directed, and how that is different from, but can lead to, opioid use disorder. A clinical assessment, not the label on the bottle, decides which one is present.

Why tramadol needs a medical plan, not just willpower

Tramadol behaves differently from most other opioids. In practice, these are the mechanisms that drive the medical decisions during a residential stay:

• Opioid activity: The liver converts tramadol into a metabolite that acts on opioid receptors, so regular use produces tolerance and opioid-type withdrawal when it stops.
• Serotonin and norepinephrine effects: Tramadol also slows the reuptake of serotonin and norepinephrine, which is why stopping it can bring mood and anxiety symptoms that look more like antidepressant discontinuation than typical opioid withdrawal.
• Seizure threshold: The FDA label warns that seizures have been reported with tramadol even within the recommended dose range, and the risk rises at higher doses and when it is combined with certain antidepressants or other medications.
• Serotonin syndrome risk: Combining tramadol with SSRIs, SNRIs, MAO inhibitors or some migraine medications can cause serotonin syndrome, so the full medication list has to be reviewed before anything is added or changed.
• Genetic metabolism differences: How fast a person’s liver enzymes convert tramadol varies, which is one reason two people on the same dose can have very different experiences in withdrawal.

Alcohol and benzodiazepines change the risk again. If tramadol is used alongside either one, withdrawal from those substances carries its own seizure risk, and medical supervision is required. Never stop alcohol or benzodiazepines abruptly without a physician’s plan.

What the first week typically looks like

Most people experience a recognizable opioid withdrawal pattern: restlessness, aching muscles and joints, yawning, runny nose, sweating, stomach cramps, diarrhea and poor sleep. Symptoms from immediate-release tramadol commonly begin within a day of the last dose, while extended-release products can shift that timeline later.

A smaller group of people report symptoms that are less typical for opioids: intense anxiety or panic, tingling or numbness in the hands and feet, confusion, and occasionally unusual perceptions. Because these can be frightening and can be mistaken for a new psychiatric problem, it helps when the clinical team knows to expect them. Families visiting during week one often notice that the person seems more anxious than sick, and that is consistent with tramadol’s dual action.

In medically supervised residential care, the plan is individualized. Some people complete a gradual taper. Others are better served by starting a medication for opioid use disorder, such as buprenorphine or methadone, which the American Society of Addiction Medicine (ASAM) national practice guideline supports as effective treatment for opioid use disorder. Comfort medications for sleep, nausea and muscle aches are usually part of the plan, with careful attention to anything that could interact with tramadol’s serotonin effects.

What I see go wrong on admissions calls

From years of placing people in residential treatment, the most common miss with tramadol is not dishonesty. It is under-description. A caller says “a few pills a day,” the intake team hears a modest prescription, and the facility plans for a low-acuity admission. Then it turns out the person was taking far more than prescribed, was also on an antidepressant, and had a seizure once that nobody connected to the medication. Each of those three facts changes the medical plan, and sometimes changes which program is the right fit.

The second inconvenient truth is that tramadol is often the medication a person was switched to because it seemed safer than other opioids. That history means people and families tend to downplay it, and it is one reason we ask about tramadol specifically rather than relying on a general “any opioids?” question.

What to tell admissions: a checklist you can do today

Before you call, take ten minutes and write down the answers to these questions. If you are calling for a loved one, gather what you can and say plainly what you do not know.

1. Which product: immediate-release, extended-release, or the tramadol and acetaminophen combination tablet. Read the bottle label.
2. Daily dose in milligrams: count tablets used per day over the last 30 days and multiply by the strength printed on the label. Note the highest single day, not just the average.
3. Last dose: the date and time of the most recent tablet.
4. Seizure history: any seizure ever, with or without a known cause, plus any head injury or epilepsy diagnosis.
5. Every other medication: especially antidepressants, migraine medications, other opioids, sleep medications and benzodiazepines.
6. Alcohol use: a realistic count of drinks per day. Combined alcohol and tramadol use changes withdrawal safety.
7. Acetaminophen total: if the combination tablet was used, add up daily acetaminophen from all sources, since high totals raise concerns about liver health.

Then ask the admissions team one direct question: “Who will supervise the taper or medication start, and how often will vital signs be checked in the first 72 hours?” A clear answer is a good sign. You can reach our team at (877) 328-1968 to walk through this list together, and you can also verify insurance benefits before the call so cost questions do not delay a safe start.

How residential treatment builds on detox

Withdrawal management is the beginning, not the treatment itself. In residential treatment, the work shifts to the reasons the dose climbed: untreated pain, sleep problems, anxiety, depression, or stress that the medication was quietly managing. A good program coordinates with a pain specialist where needed, so that leaving tramadol does not mean leaving pain untreated. Non-opioid pain approaches, physical therapy and behavioral therapies are typically part of that plan.

Discharge planning should include whether to continue a medication for opioid use disorder, naloxone for the home, and a follow-up appointment with a prescriber who knows the full history. The SAMHSA National Helpline at 1-800-662-4357 offers free, confidential referral information around the clock, and the CDC overdose prevention resources explain how lost tolerance after a period of abstinence raises overdose risk if use resumes.

Safety first

If someone taking tramadol has a seizure, becomes very confused, has a high fever with muscle rigidity or twitching, or has slow or shallow breathing, call 911. Naloxone can reverse opioid effects and should be given if an overdose is suspected, but it is not a seizure treatment, so emergency care is still needed. If you or someone you love is in emotional crisis, call or text 988.

If tramadol has become harder to stop than expected, you do not have to sort out the medical plan alone. Call (877) 328-1968 and we will help you understand the options, the level of care that fits, and what to bring on admission day. You can read more about our clinical background on Jonathan Beazley’s profile.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a licensed physician or addiction specialist. Do not stop or change any prescribed medication, including tramadol, alcohol or benzodiazepines, without medical supervision.

Gabapentin (brand name Neurontin) and pregabalin (Lyrica) are prescribed every day for nerve pain, seizures, and sometimes off-label for anxiety, sleep, or alcohol withdrawal. Because they arrive from a pharmacy with a doctor’s name on the label, many people don’t think of them as part of their substance use at all. In residential admissions, that is exactly why they get missed. This guide covers how these medications are handled when someone enters residential treatment, why stopping them suddenly is not safe, and what to have ready before you call admissions.

The Short Answer: Gabapentin Should Not Be Stopped Abruptly

Gabapentin should never be stopped “cold turkey” on admission to residential treatment. The FDA-approved prescribing information for Neurontin directs that when the medication is reduced or discontinued, it be done gradually over a minimum of one week, and it warns that antiepileptic drugs should not be stopped abruptly because of the possibility of increased seizure frequency. People who have been taking more than prescribed, or combining gabapentin with alcohol, benzodiazepines, or opioids, generally need a slower, medically supervised taper than that one-week floor, planned by a prescriber who knows their full history.

Why Gabapentin and Pregabalin Misuse Is Often Missed

From the admissions side, the pattern is consistent: a person describes their alcohol or opioid use in detail, then mentions gabapentin almost as an afterthought, or not at all. Several things drive that:

• It is prescribed, not purchased: A pharmacy label makes the medication feel like healthcare rather than substance use, even when the daily amount has drifted well past the prescription.
• Gabapentin is not federally controlled: Pregabalin is a Schedule V controlled substance under federal law, but gabapentin is not federally scheduled, so it can fall outside the questions people expect to be asked.
• It is used to manage other substances: Some people use gabapentin to soften opioid withdrawal or to blunt alcohol cravings, so they see it as part of the solution rather than part of the problem.
• It amplifies other depressants: Taken with opioids or alcohol, gabapentin can intensify sedation, which is part of why some people take extra and part of why the combination is dangerous.

None of this means a gabapentin prescription is a problem in itself. Many people take it exactly as directed and benefit. The clinical question in admissions is simply whether the amount, the source, and the combination with other substances match the prescription.

The Breathing Risk When Gabapentinoids Are Combined With Opioids

In December 2019, the U.S. Food and Drug Administration added warnings that gabapentin and pregabalin can cause serious breathing difficulties in people with respiratory risk factors, including people who also use opioids or other central nervous system depressants, older adults, and people with lung conditions such as COPD. This matters for residential admissions because many people entering treatment for opioid use disorder are also taking gabapentin, prescribed or not.

The Centers for Disease Control and Prevention (CDC) describes how combining opioids with other sedating substances raises overdose risk. A complete medication list lets the medical team plan withdrawal care and make sure naloxone is part of the safety plan. If you are worried about someone right now, and they are hard to wake, breathing slowly, or making snoring or gurgling sounds, call 911.

What Withdrawal Can Look Like in the First Week

People who have been taking high daily amounts and stop suddenly may report anxiety, agitation, restlessness, insomnia, sweating, nausea, and a rebound of the pain the medication was treating. Seizures are the most serious risk, especially for anyone with a seizure history or who is also coming off alcohol or benzodiazepines.

That last point is critical. Alcohol withdrawal and benzodiazepine withdrawal both carry a risk of seizures and can be life-threatening. Medical supervision is required. When gabapentin or pregabalin dependence overlaps with either of those, withdrawal planning needs to account for all of them at once. Families sometimes notice the first week as a person who seems “on edge” and unable to sleep, and that is a reason to keep the medical team informed, not a reason to give an extra dose from the home supply.

The National Institute on Drug Abuse (NIDA) notes that medically managed withdrawal is only the first stage of treatment and is rarely enough on its own to sustain recovery. The taper is the start, not the treatment.

What to Tell Admissions: A Checklist to Fill In Today

Before you call, take five minutes and write down the following. If you are calling for a family member, gather what you can and leave the rest blank. Admissions can work with partial information, but not with information nobody mentions.

1. Exact product and strength: Gabapentin or pregabalin, the milligram strength printed on the bottle, and whether it is capsules, tablets, or liquid.
2. Prescribed amount versus actual amount: What the label says per day, and what is actually being taken per day. Count what is left in the bottle against the fill date if you are unsure.
3. Source: One prescriber, more than one prescriber, or obtained from someone else. This is clinical information, not a judgment.
4. Time of the last dose: Withdrawal planning depends on it.
5. Everything else taken alongside it: Opioids, buprenorphine or methadone, benzodiazepines, alcohol, sleep medications, or muscle relaxants.
6. Seizure history: Any past seizure, including during a previous withdrawal.
7. Why it was first prescribed: Nerve pain, seizures, anxiety, or sleep. The underlying condition still needs a treatment plan after the taper.

Bring the original pharmacy bottles on admission day. Our admissions team can walk you through what to bring and how prescriptions are reconciled when you call (877) 328-1968.

How Residential Treatment Handles the Taper

In a residential setting, gabapentin or pregabalin is typically reviewed by the medical team during intake. The prescriber confirms the actual daily amount, considers other substances and health conditions, and sets a taper schedule. Doses are held and dispensed by staff rather than self-administered, which removes the guesswork and the temptation to take extra on a hard night.

Because the taper usually runs alongside therapy rather than before it, people can begin residential treatment work in the first days instead of waiting for withdrawal to finish. If pain was the original reason for the prescription, the plan should include non-addictive pain strategies and a handoff to an outpatient prescriber at discharge. The Substance Abuse and Mental Health Services Administration (SAMHSA) emphasizes treating co-occurring physical and mental health conditions alongside substance use, and chronic pain is one of the most common examples.

A residential stay is not the right level of care for everyone who takes gabapentin. Someone taking it exactly as prescribed, with no other substance use, may simply need their own prescriber to manage a taper. Residential care makes sense when the medication is part of a broader pattern, when other depressants are involved, or when previous attempts to cut back on their own have not held.

Questions to Ask Before You Commit to a Program

• Does the program have a prescriber on staff who reviews gabapentin and pregabalin at intake, rather than stopping all non-essential medications?
• How is a taper handled when alcohol, benzodiazepines, or opioids are also involved?
• Is naloxone included in the discharge plan for anyone with opioid use?
• What happens to the original pain or anxiety condition after the taper ends?
• Will my insurance cover the stay? You can start that process through our insurance verification page.

A Note From the Clinical Side

The most useful thing a person or family can do is mention gabapentin or pregabalin on the very first call, even if it seems minor. Medication that is disclosed can be tapered safely. Medication that surfaces on day three, after a withdrawal symptom nobody planned for, is harder for everyone. If you are not sure whether it matters, assume it does and say it out loud.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. To talk through a specific situation confidentially, call (877) 328-1968.

This article is for educational purposes only and is not medical advice. Do not stop, reduce, or change any prescribed medication without guidance from your prescriber. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.

Ketamine rarely comes up first on an admissions call. People mention alcohol, pills, or stimulants, and ketamine surfaces ten minutes in, usually described as “not really the problem” or “something my doctor started.” This guide covers what residential treatment actually does when ketamine is part of the picture: how use is assessed, why there is no detox medication for it, what happens to the bladder, how a legitimate ketamine prescription is handled, and exactly what to tell admissions so the first week is planned correctly. If you want to talk it through now, call (877) 328-1968.

The Short Version: How Ketamine Is Classified and Treated

Ketamine is a Schedule III controlled substance under federal law, approved as an anesthetic, and there is no FDA-approved medication for treating ketamine use disorder. Esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, can only be given in a certified healthcare setting, where the patient is monitored for at least two hours after each dose and cannot take the medication home. So when someone has ketamine at home in powder, liquid, or lozenge form, it is either illicit, diverted, or prescribed off-label by a telehealth or clinic prescriber, and residential treatment for problematic ketamine use relies on medical monitoring, symptom management, and behavioral therapy rather than a replacement medication.

How Admissions Decides Whether Ketamine Use Is a Disorder

In the DSM-5, ketamine falls under the phencyclidine-type substances. A use disorder is diagnosed when at least two of the listed criteria occur within a 12-month period: using more than intended, failed attempts to cut down, cravings, giving up activities, continued use despite physical or psychological harm, tolerance, and so on. One difference matters for planning: unlike alcohol or opioids, the criteria list does not include a defined withdrawal syndrome. That does not mean stopping is easy. It means the difficult part is usually psychological rather than a predictable physical withdrawal curve.

A clinician will also use the ASAM Criteria to decide whether residential treatment is the right level of care, looking at medical risk, mental health, readiness, and how safe the home environment is.

Why Ketamine Use Escalates

From the admissions side, these are the patterns that come up again and again. They are clinical observations, not a checklist for self-diagnosis.

• Fast tolerance: The dissociative effect fades with repeated use, so people take larger amounts or use more often to get the same distance from their thoughts.
• Dissociation as relief: For someone with depression, anxiety, or trauma, the detached state can feel like the first break in months, which makes it hard to see the use as a problem.
• The prescription bridge: Some people start with ketamine for depression and begin taking extra doses between sessions or buying more when the supply runs out.
• Short effect, repeated dosing: The effects wear off relatively quickly, which encourages several doses in a single night.
• Mixing with depressants: Ketamine is often combined with alcohol or benzodiazepines, which raises the risk of dangerous sedation and slowed breathing.

What the First Week Actually Looks Like

Because there is no standard ketamine detox protocol, the first days in residential care are about watching closely and treating what shows up. People commonly describe low mood, poor or broken sleep, fatigue, irritability, strong cravings, and a flat, foggy feeling sometimes described as “not being back in my body yet.” Families often notice the person sleeping far more than usual early on, then becoming restless and anxious later in the week.

Mood is the part the clinical team watches most closely. When ketamine has been masking depression, that depression can return quickly once use stops. Staff will check in on mood and safety daily and coordinate with psychiatry. If co-occurring depression or anxiety is significant, integrated mental health treatment runs alongside the substance use work rather than after it. The National Institute of Mental Health notes that substance use disorders and mental health conditions frequently occur together and are best treated together.

A safety note that matters more than the ketamine itself: if ketamine has been used alongside daily alcohol or benzodiazepines, withdrawal from those substances can cause seizures and can be life-threatening. That withdrawal requires medical supervision. Do not stop alcohol or benzodiazepines suddenly on your own before admission. Tell admissions exactly how much and how often, so the medical team can plan a supervised taper.

The Bladder Problem Nobody Mentions on the Phone

Regular ketamine use is linked to damage to the bladder and urinary tract, sometimes called ketamine-associated uropathy or ketamine cystitis. Symptoms include needing to urinate very often, urgency, pain when the bladder fills or empties, and blood in the urine. Many people have lived with these symptoms for months and assume they are a recurring urinary tract infection that antibiotics never quite clear.

Stopping ketamine is the most important step, and some people see improvement after they stop, but severe or long-standing damage may need a urologist. A residential medical team can order a urine test, track symptoms, and arrange a referral. Visible blood in the urine, inability to urinate, fever, or severe pain needs prompt medical evaluation, not a wait-and-see approach.

If Your Ketamine Is Prescribed

A legitimate prescription does not disqualify anyone from treatment, and it does not have to be hidden. What admissions needs is the full picture: who prescribes it, the dose, the form, how often it is taken, and whether actual use matches the prescription. If it does match, the medical team will usually contact the prescriber, with your written consent, to decide together whether to pause, continue, or replace it with a different depression treatment during the stay. If use has gone beyond the prescription, say so plainly. It changes the treatment plan, and it is far better for the team to know on day one than to find out on day five.

Do not stop a prescribed depression treatment abruptly before admission without talking to the prescriber first, because mood can drop quickly.

What to Tell Admissions: A Checklist You Can Use Today

Before you or your loved one calls, write these down. It takes about ten minutes and makes the intake assessment much more accurate.

1. Form and route: powder (snorted), liquid, lozenge, injection, or prescribed nasal or clinic treatment.
2. Amount and frequency: a typical day or weekend, and the date and time of last use.
3. Everything else used with it: alcohol, benzodiazepines, opioids, stimulants, cannabis, with amounts for each.
4. Bladder symptoms: how many times a day you urinate, any pain, and any blood. If you can, keep a simple tally for the next 24 hours.
5. Mental health history: diagnoses, current medications, and any past suicide attempts or recent thoughts of suicide.
6. Prescriber details: name, clinic, and phone number if ketamine or esketamine is prescribed.
7. Insurance card: front and back. You can start a check through our insurance verification page.

Then ask admissions this one question directly: “How will your medical team monitor mood and bladder symptoms in the first week, and who coordinates with my prescriber?” A program that has thought about ketamine will have a specific answer.

For Families: What You Can Do Right Now

Families often see the bathroom trips, the long periods of staring or seeming disconnected, and the mood crashes before the person admits there is a problem. You do not need to prove anything to start a conversation with admissions. Write down what you have observed and when, and call. If the person is unsafe, unresponsive, or talking about suicide, call 911 or the 988 Suicide & Crisis Lifeline by calling or texting 988. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available, and the National Institute on Drug Abuse maintains research-based information on substances and treatment.

Getting Started in Northern California

Ketamine use is treatable, and recovery does not depend on a medication that does not exist. It depends on a careful first week, honest information at intake, and treatment that addresses whatever the ketamine was covering up. Our admissions team can walk you through the assessment, insurance, and next steps. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can be dangerous and should only happen under medical supervision. If you or someone you know is in crisis, call or text 988 or call 911.

Most people calling about residential treatment ask about insurance, length of stay and what to pack. Far fewer ask the question that most often causes a problem on admission day: what happens to the medications I already take? Blood pressure pills, an antidepressant, an inhaler, a stimulant for ADHD, a sleep aid, a benzodiazepine prescribed years ago. Every one of them has to be accounted for before the first night, and the process that does it has a name: medication reconciliation.

This guide explains how that process works in a residential setting, why controlled prescriptions are handled differently, and exactly what to have ready before you call admissions.

What Medication Reconciliation Means in Residential Treatment

Medication reconciliation in residential addiction treatment is the process of comparing every medication a person reports taking, including prescriptions, over-the-counter products and supplements, against pharmacy records and prescriber information, so the medical team can decide on the first day which medications continue unchanged, which are adjusted, which are tapered under supervision, and which are paused. It is completed at intake and repeated at discharge, and it depends heavily on how complete and accurate the list the person brings with them is.

In practice, the medical team is answering four questions for each item: Is it actually prescribed to this person? Is it being taken as prescribed? Does it interact with withdrawal management or with medications for addiction treatment? And is stopping it suddenly safe?

Why Controlled Prescriptions Get a Closer Look

Most routine medications, such as those for blood pressure, thyroid, diabetes or asthma, simply continue. The closer review is reserved for medications that can cause dependence or that change how withdrawal behaves.

Benzodiazepines: stopping them abruptly after regular use can cause seizures, so any change must be a supervised taper, never a sudden stop.

Opioid pain medications: combined with benzodiazepines or alcohol they raise the risk of dangerously slowed breathing, which affects how both are managed.

Stimulants prescribed for ADHD: the team weighs the documented diagnosis against current substance use before deciding whether to continue, adjust or pause.

Sleep medications and sedating supplements: these can stack with withdrawal medications and with each other, so the full list matters, including products bought without a prescription.

The U.S. Food and Drug Administration (FDA) has addressed the risks of benzodiazepine and opioid prescriptions directly. In August 2016 it required boxed warnings, its most prominent safety label, on opioid and benzodiazepine products about the dangers of using them together. In September 2020 it required the boxed warning on all benzodiazepines to be updated to describe the risks of misuse, addiction, physical dependence and withdrawal reactions. Those two dated label changes are a large part of why residential addiction treatment programs handle these prescriptions with extra care rather than continuing them automatically. The National Institute on Drug Abuse (NIDA) also publishes plain-language information on prescription medication misuse that families may find useful.

A Safety Point That Overrides Everything Else

If you or your loved one drinks heavily every day, or takes a benzodiazepine daily, do not stop on your own in the days before admission to “get a head start.” Withdrawal from alcohol and from benzodiazepines can cause seizures and, in severe cases, can be life-threatening. Medical supervision is required. The safest plan is usually to continue as you are, report your use honestly, and let the medical team manage the transition. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) describes alcohol withdrawal as a condition that can require medical treatment, and the American Society of Addiction Medicine (ASAM) publishes clinical guidelines for managing it.

If you are unsure whether it is safe to wait until admission, call us at (877) 328-1968 and ask to speak with someone about it before you change anything.

What We See Go Wrong on Admission Day

From years of admissions work in Northern California, the medication problems we see are rarely dramatic. They are logistical, and almost all of them are preventable:

• Pills in a pill organizer or a plastic bag. Medications that are not in the original pharmacy-labeled container usually cannot be identified and verified, so they cannot be given until a replacement is obtained. That can mean a delay of a day or more for a medication the person depends on.
• A list from memory. People commonly forget the inhaler, the eye drops, the once-weekly injection, or the supplement they take every night. Each omission is a gap in the medical picture.
• Prescriptions from several prescribers. When a primary care doctor, a psychiatrist and a pain specialist each prescribe something, no single office has the whole list. The treatment team may be the first to see it all together.
• Underreporting use. Saying “two drinks a night” when it is closer to a bottle, or “as prescribed” when it is twice the dose, does not change what the body will do in withdrawal. It only means the plan is built on the wrong numbers.

None of these reflect badly on the person. They are what happens when someone is preparing for treatment under stress. They are also easy to fix in advance.

What to Do Before You Call Admissions

Here is a short checklist you can complete today, before the admissions call or before admission day:

1. Gather every bottle. Put every prescription, over-the-counter medication and supplement you have taken in the last 30 days on one table, in its original labeled container.
2. Write one list. For each item, write the name, the dose, how often you actually take it, the prescriber, and the pharmacy. “Actually” matters more than “supposed to.”
3. Call your pharmacy. Ask for a printed medication history. Most pharmacies can provide one, and it often catches items people forget.
4. Flag the controlled ones. Circle anything that is a benzodiazepine, an opioid, a stimulant or a sleep medication, and note how long you have taken it.
5. Ask these three questions on the admissions call: “Which of my medications will continue on day one?” “If a medication needs to be tapered, who sets the schedule?” “If something I take is not continued, will my prescriber be told?”

Bring the list, the bottles and the pharmacy printout on admission day. Admissions can tell you about any program-specific rules, such as how medications are stored and dispensed. You can start that conversation at (877) 328-1968.

What Happens After Intake

Once the medical team has the list, decisions are typically made in the first hours or day. Continued medications are usually stored and dispensed by staff rather than kept by the person. Medications that are tapered follow a written schedule. If a medication for addiction treatment, such as buprenorphine or naltrexone, is part of the plan, it is checked against everything else on the list first.

Reconciliation happens again at discharge. That second pass is just as important: the person should leave with a single, current list, a clear note on anything that was changed and why, and confirmation that the outpatient prescriber has been informed. If you are planning the step after residential care, our pages on partial hospitalization and outpatient treatment explain how care typically continues. You can also read about our approach to residential treatment.

For Families Helping With Preparation

Families often end up doing the practical work: collecting bottles from the bathroom cabinet, calling the pharmacy, finding the psychiatrist’s phone number. That help is valuable. It works best when the person entering treatment is part of it, because only they know what they actually take and how often. If your loved one is reluctant to share details with you, encourage them to share them directly with admissions instead. The goal is an accurate list, not who compiles it.

For confidential, free help finding treatment and support at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year, at 1-800-662-4357. If you or someone you love is in crisis or thinking about suicide, call or text 988. In an emergency, call 911.

Talk to Bodhi Before You Change Anything

If you are preparing for residential treatment and are unsure what to do with a current prescription, the most useful step is a conversation before admission, not on the day. Call Bodhi Addiction Treatment at (877) 328-1968 to talk through your medications, your use and what to bring.

This article is for educational purposes only and is not medical advice. Do not start, stop or change any medication without guidance from a qualified healthcare provider. Withdrawal from alcohol or benzodiazepines can be dangerous and requires medical supervision.